Wiley Bros. Aintree Capital, LLC Astrazeneca PLC Transaction History
Wiley Bros. Aintree Capital, LLC
- $2.26 Billion
- Q2 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 15,621 shares of AZN stock, worth $1.22 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
15,621Holding current value
$1.22 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,332Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.08 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.33 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.18 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.87 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.38 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $243B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...